Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Keybanc Downgrades Cooper Companies to Sector Weight

Keybanc analyst Matthew Mishan downgrades Cooper Companies (NYSE:COO) from Overweight to Sector Weight.

byBenzinga Newsdesk

August 29, 2022

1 minute read

Keybanc analyst Matthew Mishan downgrades Cooper Companies (NYSE:COO) from Overweight to Sector Weight.

Data: Bitcoin Enjoying Great Market Interest Despite Crash

By Adrian Zmudzinski

Today, 2:34 AM

The world's first cryptocurrency, Bitcoin (CRYPTO: BTC), is seeing great interest from market participants, as clearly shown by market data.

BTC

Acuity Brands, Rivian And 3 Stocks To Watch Heading Into Tuesday

By Lisa Levin

Today, 2:34 AM

With US stock futures trading higher this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:

AYI

CommVault Systems Q4 Adj. EPS $0.75 Beats $0.63 Estimate, Sales $205.90M Beat $202.02M Estimate

By Benzinga Newsdesk

Today, 2:34 AM

CommVault Systems (NASDAQ:CVLT) reported quarterly earnings of $0.75 per share which beat the analyst consensus estimate of $0.63 by 19.05 percent. This is a 27.12 percent increase over earnings of $0.59 per share from

CVLT

CytomX Therapeutics Announces First Patient Dosed With CX-904 In Phase 1 Study In Patients With Advanced Solid Tumors

By Benzinga Newsdesk

Today, 2:34 AM

CytomX Therapeutics, Inc. (NASDAQ:CTMX), a leader in the field of conditionally activated oncology therapeutics, today announced that the first patient has been dosed in a Phase 1 dose-escalation study of CX-904

CTMX

Keybanc Downgrades Cooper Companies to Sector Weight

Related Posts

Data: Bitcoin Enjoying Great Market Interest Despite Crash

Acuity Brands, Rivian And 3 Stocks To Watch Heading Into Tuesday

CommVault Systems Q4 Adj. EPS $0.75 Beats $0.63 Estimate, Sales $205.90M Beat $202.02M Estimate

CytomX Therapeutics Announces First Patient Dosed With CX-904 In Phase 1 Study In Patients With Advanced Solid Tumors